Effects of diadenosine triphosphate (Ap3A) and diadenosine tetraphosphate (Ap4A) on platelet aggregation in unfractionated human blood
- 1 December 1985
- journal article
- research article
- Published by Springer Nature in Annals of Hematology
- Vol. 51 (6) , 405-413
- https://doi.org/10.1007/bf00320727
Abstract
The effects on platelet aggregation of diadenosine triphosphate (Ap3A) and diadenosine tetraphosphate (Ap4A), both of which are stored in and released from platelet granules, have been studied in unfractionated human blood using a microscopic platelet-count ratio method. Ap3A at submicromolar concentrations induces platelet aggregation whereas the homologue dinucleotide Ap4A has disaggregating potency. In the concentration range between 10−7 to 10−5 M, Ap3A has been found to be as effective as ADP in triggering aggregate formation. These results confirm and essentially extend our recent findings with platelet-rich plasma that Ap3A is able to trigger platelet aggregation by a slow release of ADP from Ap3A which is catalyzed by a plasma hydrolase. Formation of platelet aggregates was also followed kinetically using a turbidometric method which has been developed for this purpose. In contrast to ADP which very rapidly induces a transient state of aggregation, the effect of Ap3A occurs much more slowly but induces the same maximum of aggregation. The duration of the Ap3A stimulus, however, is longer than that of ADP pointing to a potential physiological function of Ap3A as a “masked” source for ADP.Keywords
This publication has 17 references indexed in Scilit:
- Catabolism of Ap3A and Ap4A in human plasma. Purification and characterization of a glycoprotein complex with 5'-nucleotide phosphodiesterase activityEuropean Journal of Biochemistry, 1985
- Molecular events involved in the proaggregating effect of heparin on human plateletsBiochimica et Biophysica Acta (BBA) - General Subjects, 1984
- Role of red cells in preventing the growth of platelet aggregationThrombosis Research, 1984
- Diadenosine triphosphate (Ap3A) mediates human platelet aggregation by liberation of ADPBiochemical and Biophysical Research Communications, 1984
- Diadenosine 5′,5‴-P1,P3-triphosphate in eukaryotic cells: Identification and quantitationAnalytical Biochemistry, 1983
- The presence of diadenosine 5′,5‴-P 1 ,P 3 -triphosphate (Ap 3 A) in human plateletsBiochemical and Biophysical Research Communications, 1983
- Abundant amounts of diadenosine 5′,5‴-P1,P4-tetraphosphate are present and releasable, but metabolically inactive, in human plateletsBiochemical Journal, 1982
- Inhibition of platelet aggregation and the platelet release reaction by α, ω diadenosine polyphosphatesFEBS Letters, 1975
- A NEW METHOD FOR THE QUANTITATIVE DETECTION OF PLATELET AGGREGATES IN PATIENTS WITH ARTERIAL INSUFFICIENCYThe Lancet, 1974
- Comparison of the effect of heparin and citrate on platelet aggregationJournal of Clinical Pathology, 1969